Renalytix Collaborates With ADA To Improve Early Detection Of Kidney Disease

10 Jan 2022

The American Diabetes Association and Renalytix will develop a comprehensive interprofessional risk-informed Diabetes Kidney Care Pathway and Model for optimal clinical treatment and risk reduction that can be applied nationally.

Kidney disease. 3d illustration. — • Source: Shutterstock

Renalytix AI, the developer of the KidneyIntelX kidney disease prognosis platform, is partnering with the American Diabetes Association to improve early diagnosis and treatment of kidney disease in people with type 2 diabetes.

Renalytix is focused on “bioprognosis” of kidney health. The company’s lead product, KidneyIntelX is an artificial intelligence platform for assessing...